Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Creative Biolabs has developed a cutting-edge Immune Monitoring platform for the evaluation and development of Immune-oncology Biomarkers and the application of biomarkers for immune monitoring. Gene expression microarray, which is available to provide both static and dynamic views of gene expression patterns in cells and tissues, is one of our powerful strategies for immune biomarker identification. Our years of experience and flexible service options for gene expression analysis can help deliver fast and reliable support for our clients' biomarker development projects.
Numerous immune biomarkers have been described to be related to the tumor stage and prognosis of cancer patients. Powerful biomarkers in detecting superficial diseases or predicting the clinical outcome of individual tumors are limited and in demand. High-throughput gene expression microarrays represent novel approaches for immune marker discovery. Gene expression microarrays are frequently used to simultaneously analyze the expression level of tens of thousands of genes. Analysis of microarray data has become a useful tool for the study of different diseases including all types of cancer. In cancer research, gene expression microarrays can be used for various purposes such as eliciting a prognosis, characterizing a particular illness stage, or detecting the role of specific genes in cancer development. Moreover, the tremendous increase in the DNA sequence information available through genome sequencing efforts has greatly promoted the development of gene expression microarrays for immune biomarker discovery.
At Creative Biolabs, optimization methods, aiming to find the best compromises between several conflicting criteria, is proposed for the identification of potential cancer biomarkers from microarray data. The genes, which are built with performance measures relating to the significant change in gene expression, are potential cancer biomarkers. Our seasoned scientists are proficient in applying gene expression microarray analysis techniques for the identification of potential cancer biomarkers.
Our featured services include experimental design, RNA quality control (QC), target labeling, array hybridization, washing and processing, array image scanning, data QC and normalization, differential gene expression analysis, and potential biomarker discovery. Consistent results can be achieved across several experiments and researches. Moreover, our comprehensive microarray services include the use of custom synthesized microarrays which enables the total customization of content on each microarray to meet our clients' needs.
Creative Biolabs is always dedicated to assisting our clients with the most satisfactory gene expression microarray analysis techniques for the identification of potential cancer biomarkers. If you are interested in immune biomarker development, please feel free to contact us or directly send us an inquiry.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
